This Viewpoint advocates for more careful consideration of families and children in policymaking surrounding naloxone coprescribing or accessibility. Share: Previous Post Effects on Body Mass Index After the Philadelphia Beverage Tax Next Post JAMA Pediatrics Related Articles Clinical Practice Guidelines Neurodiversity and Early Autism Clinical Practice Guidelines JAMA Pediatrics Peer Reviewers in 2023 Clinical Practice Guidelines Persistence of Autism Spectrum Disorder From Early Childhood Through School Age Clinical Practice Guidelines Peripartum Outcomes Associated With COVID-19 Vaccination During Pregnancy Clinical Practice Guidelines JAMA Pediatrics Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.